![Benjamin Auspitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Benjamin Auspitz
Director/Board Member at
Symbiomix Therapeutics LLC
Profile
Benjamin A. Auspitz was the founder of Dimension Therapeutics, Inc., founded in 2013, where the title held was Chairman.
Current jobs include Director at Symbiomix Therapeutics LLC, Director at Meves Pharmaceuticals, Inc., Director at Modis Therapeutics, Inc., Director at Zero Point Five Therapeutics, Inc., and Managing Partner at Curie Bio Operations LLC starting in 2025.
Former jobs include Director-Therapeutic Area at CombinatoRx, Inc., Director at Precision BioSciences, Inc., Director at REGENXBIO, Inc., Independent Director at Ultragenyx Pharmaceutical, Inc., Director at Compass Therapeutics LLC, Director at Cogent Biosciences, Inc., Director at LigoCyte Pharmaceuticals, Inc., Director at Checkmate Pharmaceuticals, Inc., Director at Turnstone Biologics, Inc., Director at Orchard Therapeutics (Europe) Ltd. from 2016 to 2018, Director at Xilio Therapeutics, Inc., Consultant at Braun Consulting, Inc. in 2000, Consultant at Vertex Partners in 1997, and Partner at F-Prime, Inc. Education includes undergraduate degree from Harvard University.
Benjamin Auspitz active positions
| Companies | Position | Start |
|---|---|---|
Symbiomix Therapeutics LLC
 Symbiomix Therapeutics LLC BiotechnologyHealth Technology Develops medicines for prevalent gynecologic infections | Director/Board Member | - |
Modis Therapeutics, Inc.
 Modis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology for developing disease modifying therapies | Director/Board Member | - |
Meves Pharmaceuticals, Inc.
 Meves Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | - |
Zero Point Five Therapeutics, Inc.
 Zero Point Five Therapeutics, Inc. BiotechnologyHealth Technology Operates as a drug development company focused on neglected tropical diseases and soil-transmitted helminthiasis | Director/Board Member | - |
Curie Bio Operations LLC
 Curie Bio Operations LLC Investment ManagersFinance Curie Bio invests in companies located in the United States. The firm targets companies operating in the fields of the biotech. It provides financing for seed stage capital requirements. | Private Equity Analyst | 01/01/2025 |
Former positions of Benjamin Auspitz
| Companies | Position | End |
|---|---|---|
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Chairman | 11/04/2018 |
| REGENXBIO INC. | Director/Board Member | 01/05/2015 |
LigoCyte Pharmaceuticals, Inc.
 LigoCyte Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Developed vaccines and monoclonal antibody therapeutics | Director/Board Member | 16/04/2014 |
Braun Consulting, Inc.
 Braun Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides IT consulting services | Corporate Officer/Principal | 01/01/2000 |
| ░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Benjamin Auspitz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
15
1st degree connections
21
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 21 |
|---|---|
Braun Consulting, Inc.
Braun Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides IT consulting services | Commercial Services |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Health Technology |
Precision BioSciences, Inc.
 Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research | Health Technology |
REGENXBIO, Inc.
 REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Health Technology |
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Develops medicines for prevalent gynecologic infections | Health Technology |
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vertex Partners
 Vertex Partners Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
LigoCyte Pharmaceuticals, Inc.
LigoCyte Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Developed vaccines and monoclonal antibody therapeutics | Health Technology |
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for rare diseases | Health Technology |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America and South America. The firm targets companies operating in the fields of life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Finance |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Turnstone Biologics, Inc.
 Turnstone Biologics, Inc. BiotechnologyHealth Technology Develops bio-therapeutics for the treatment of cancer | Health Technology |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Meves Pharmaceuticals, Inc.
Meves Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Modis Therapeutics, Inc.
Modis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology for developing disease modifying therapies | Commercial Services |
Curie Bio Operations LLC
Curie Bio Operations LLC Investment ManagersFinance Curie Bio invests in companies located in the United States. The firm targets companies operating in the fields of the biotech. It provides financing for seed stage capital requirements. | Finance |
Zero Point Five Therapeutics, Inc.
Zero Point Five Therapeutics, Inc. BiotechnologyHealth Technology Operates as a drug development company focused on neglected tropical diseases and soil-transmitted helminthiasis | Health Technology |
- Stock Market
- Insiders
- Benjamin Auspitz
